Karyopharm Therapeutics Inc (KPTI) Insider Trading
- $10,245,912.22
- $140,920,789.20
- April 22, 2024
- Ltd Chione
Trader Name | Date | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|---|
April 22, 2024 | EVP | 6,789 | $1.17 | Sell | $7,943.13 | |
April 4, 2024 | CEO | 3,563 | $1.29 | Sell | $4,596.27 | |
March 5, 2024 | CEO | 3,573 | $1.30 | Sell | $4,644.90 | |
Feb. 29, 2024 | CEO | 80,470 | $1.17 | Sell | $94,149.90 | |
Feb. 29, 2024 | EVP | 15,667 | $1.17 | Sell | $18,330.39 | |
Feb. 29, 2024 | SVP | 16,973 | $1.17 | Sell | $19,858.41 | |
Feb. 29, 2024 | CFO | 27,687 | $1.17 | Sell | $32,393.79 | |
Feb. 27, 2024 | CFO | 2,545 | $1.32 | Sell | $3,359.40 | |
Feb. 15, 2024 | EVP | 5,847 | $1.33 | Sell | $7,776.51 | |
Feb. 6, 2024 | CFO | 4,205 | $1.59 | Sell | $6,685.95 | |
Feb. 6, 2024 | CEO | 4,012 | $1.59 | Sell | $6,379.08 | |
Jan. 4, 2024 | CEO | 4,114 | $0.82 | Sell | $3,373.48 | |
Dec. 4, 2023 | CEO | 3,622 | $0.79 | Sell | $2,861.38 | |
Nov. 6, 2023 | CEO | 3,606 | $0.92 | Sell | $3,317.52 | |
Oct. 4, 2023 | CEO | 3,589 | $1.27 | Sell | $4,558.03 | |
Sept. 12, 2023 | Director | 41,140 | $1.22 | Buy | $50,190.80 | |
Sept. 1, 2023 | CFO | 6,913 | $1.33 | Sell | $9,194.29 | |
Sept. 1, 2023 | SVP | 3,888 | $1.33 | Sell | $5,171.04 | |
Sept. 1, 2023 | EVP | 7,415 | $1.33 | Sell | $9,861.95 | |
Aug. 7, 2023 | CEO | 3,722 | $1.72 | Sell | $6,401.84 | |
July 28, 2023 | EVP | 2,845 | $1.70 | Sell | $4,836.50 | |
July 5, 2023 | CEO | 3,538 | $1.72 | Sell | $6,085.36 | |
June 8, 2023 | EVP | 1,839 | $2.35 | Sell | $4,321.65 | |
May 4, 2023 | CEO | 3,805 | $3.35 | Sell | $12,746.75 | |
April 20, 2023 | EVP | 6,770 | $4.05 | Sell | $27,418.50 | |
April 4, 2023 | CEO | 3,497 | $3.97 | Sell | $13,883.09 | |
March 6, 2023 | CEO | 3,506 | $3.16 | Sell | $11,078.96 | |
March 1, 2023 | CEO | 33,033 | $3.03 | Sell | $100,089.99 | |
March 1, 2023 | SVP | 6,357 | $3.03 | Sell | $19,261.71 | |
March 1, 2023 | EVP | 11,239 | $3.03 | Sell | $34,054.17 | |
March 1, 2023 | CFO | 11,205 | $3.03 | Sell | $33,951.15 | |
Feb. 15, 2023 | EVP | 5,869 | $3.19 | Sell | $18,722.11 | |
Jan. 4, 2023 | CEO | 3,922 | $3.27 | Sell | $12,824.94 | |
Dec. 5, 2022 | CEO | 3,490 | $5.17 | Sell | $18,043.30 | |
Nov. 4, 2022 | CEO | 3,493 | $4.54 | Sell | $15,858.22 | |
Oct. 4, 2022 | CEO | 3,488 | $5.87 | Sell | $20,474.56 | |
Sept. 8, 2022 | CEO | 3,479 | $5.23 | Sell | $18,195.17 | |
Aug. 4, 2022 | CEO | 2,314 | $4.48 | Sell | $10,366.72 | |
July 8, 2022 | CEO | 2,115 | $5.18 | Sell | $10,955.70 | |
July 8, 2022 | President and CEO | 2,115 | $5.18 | Sell | $10,955.70 | |
June 13, 2022 | Insider | 1,551 | $5.21 | Sell | $8,080.71 | |
June 7, 2022 | CEO | 2,542 | $5.76 | Sell | $14,641.92 | |
June 3, 2022 | CFO | 601 | $6.04 | Sell | $3,630.04 | |
Feb. 7, 2022 | Insider | 6,707 | $9.86 | Sell | $66,131.02 | |
Feb. 7, 2022 | CFO | 3,947 | $9.86 | Sell | $38,917.42 | |
Feb. 7, 2022 | Director | 6,764 | $9.86 | Sell | $66,693.04 | |
Feb. 7, 2022 | EVP | 1,704 | $9.86 | Sell | $16,801.44 | |
Dec. 2, 2021 | SVP | 499 | $6.69 | Sell | $3,338.31 | |
May 7, 2021 | EVP | 23,250 | $8.60 | Buy | $199,950.00 | |
May 6, 2021 | Director | 4,000 | $7.82 | Buy | $31,280.00 |
Insiders are both buying and selling Karyopharm Therapeutics Inc stock.
The insider traders at Karyopharm Therapeutics Inc are: Ltd Chione, Michael Kauffman, Sharon Shacham, Richard A Paulson, Christopher Brett Primiano, Mansoor Raza Mirza, Marcin Czernik, Michael Mason, Jatin Shah, Sohanya Roshan Cheng, Reshma Rangwala, Stuart Poulton, Deepika Pakianathan, Ran Frenkel, Garen G Bohlin, Stephen Mitchener, Michael Mano, Tanya Lewis, John Demaree, Justin A Renz, Ltd Plio, Paul Brannelly, Paulson Richard A., and Barry E Greene
The most active insider trader at Karyopharm Therapeutics Inc is Ltd Chione with 36 trades.
Ltd Chione has sold the most Karyopharm Therapeutics Inc stock with a total value of $91,689,798.39.
Deepika Pakianathan has bought the most Karyopharm Therapeutics Inc stock with a total value of $10,995,453.42.
The most recent insider trade for Karyopharm Therapeutics Inc was on April 22, 2024.
The single biggest insider buy for Karyopharm Therapeutics Inc was from Deepika Pakianathan with a total value of $5,000,000.00 on Nov. 12, 2013.
The single biggest insider sell for Karyopharm Therapeutics Inc was from Ltd Plio with a total value of $17,770,000.00 on July 23, 2014.